Skip to main content
. Author manuscript; available in PMC: 2014 May 28.
Published in final edited form as: J Med Chem. 2013 Mar 27;56(7):2804–2812. doi: 10.1021/jm301538e

Figure 4.

Figure 4

(A) Plaque reduction assay with A/WSN/33-S31N influenza virus. (B) Plaque reduction assay with A/WSN/33-N31S (WT) virus. The inhibitory effect of compound 44 and amantadine on influenza A virus replication was evaluated by plaque formation in MDCK cells as described in the Experimental Section (Supporting Information).